Latest News and Press Releases
Want to stay updated on the latest news?
-
Ottawa, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The global cardiovascular drugs market size accounted for USD 144.11 billion in 2023, and grew to USD 149.99 billion in 2024, According to Precedence...
-
Fort Collins, Colorado, Oct. 10, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the cardiovascular drugs market size was valued at USD 147.7 Billion in 2022 and is expected to reach...
-
Westford, USA, Aug. 30, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, increasing prevalence of cardiovascular diseases worldwide is propelling demand for effective drugs. As lifestyle-related risk...
-
Pune, India, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The global cardiovascular drugs market size is set to touch USD 63.96 billion by 2026, exhibiting a CAGR of 3.8% during the forecast period....
-
New York, Aug. 16, 2022 (GLOBE NEWSWIRE) -- According to Precedence Research, the global cardiovascular drugs market size was accounted at USD 162.64 billion in 2022. The rapid modernization has...
-
Pune, India, Sept. 24, 2021 (GLOBE NEWSWIRE) -- According to the report, Cardiovascular Drugs Market size is projected to reach USD 63.96 billion at CAGR to 3.8% by 2026. The increasing demand for...
-
Pune, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Global cardiovascular drugs market is projected to reach USD 63.96 billion by 2026, exhibiting a CAGR of 3.8% during the forecast period. The increasing...
-
Pune, Nov. 26, 2019 (GLOBE NEWSWIRE) -- The global Cardiovascular Drugs Market is projected to reach USD 63.96 billion by 2026, exhibiting a CAGR of 3.8% during the forecast period. The increasing...
-
Albany, New York, Aug. 20, 2019 (GLOBE NEWSWIRE) -- The global Cardiovascular Drugs Market was valued approximately US$ 80.0 Bn in 2016 and is anticipated to register CAGR of over 1.0% from 2017 to...
-
Albany, NY, July 25, 2018 (GLOBE NEWSWIRE) -- The global cardiovascular drugs market was valued at US$ 80.0 bn in 2016 is projected to register a CAGR of over 1.0% from 2017 to 2025, The report...